Euro Biotech News

Six GMO maize events sail through commission

Fri, 30 Jul 2010 04:31:13 +0200

Brussels - The European Commission approved the import of six types of genetically modified (GM) maize - after the usual deadlock on national levels. The European Commission has...

�50m government fund for access to new cancer drugs

Thu, 29 Jul 2010 08:13:12 +0200

Britain's coalition government plans to boost the sale and use of innovative cancer drugs in the British Health system. Health Secretary Andrew Lansley said that, starting in...

Cerenis SA collects EUR 50m from French government and private investors

Wed, 28 Jul 2010 06:56:11 +0200

Cerenis Therapeutics SA raised EUR40m in a Series C financing round from the French Government and existing investors. The company, based in Toulouse, France, and Ann Arbor,...

Sanofi in pursuit of Genzyme

Tue, 27 Jul 2010 05:08:30 +0200

Paris-based drug company Sanofi-Aventis appears to be considering spending more than US-$20 billion for Genzyme Corp., the Wall Street Journal reported citing informed circles....

International Stem Cell Corporation sets up $10m European subsidiary

Mon, 26 Jul 2010 07:27:11 +0200

The International Stem Cell Corporation wants to set up shop in Europe. The California-based biotechnology company announced today that it had entered into Memorandum of...

Novagali's IPO raises EUR22m

Fri, 23 Jul 2010 02:59:11 +0200

Novagali Pharma, a French pharmaceutical company specialized in
ophthalmology, has raised EUR22m in an IPO on Euronext Paris and a private
placement to institutional...

Actelion obtains option to acquire privately-held Trophos

Thu, 22 Jul 2010 02:29:36 +0200

Allschwil / Marseille - The Swiss biotech company Actelion pays EUR10m to get a first hand on French Trophos SA. The two companies entered a binding agreement whereby Actelion has...

EU invests EUR6.4 billion in research 2011

Wed, 21 Jul 2010 01:23:20 +0200

Brussels - The European Union will boost research projects in science and industry with €6.4 billion in 2011, the largest ever allocation for research and innovation. 35 percent...

Vernalis loses Parkinson compound

Tue, 20 Jul 2010 00:38:39 +0200

London - Vernalis and its US-partner Biogen Idec have halted the development of a drug for Parkinson's disease. Vipadenant, a novel adenosine A2A receptor antagonist and one of...

World's biggest aids congress in Vienna

Mon, 19 Jul 2010 02:55:30 +0200

An estimated 20,000 participants from over 185 countries are taking part in the 18th International AIDS Conference that began in Vienna on Sunday. The head of the International...

Evotec AG to bag DeveloGen AG

Fri, 16 Jul 2010 08:08:25 +0200

Hamburg/G�ttingen - Hamburg-based drug screening specialist Evotec AG has entered into a definitive agreement with a group of shareholders from diabetes and obesity drug-developer...

High-Level Expert Group put biotechnology on top

Thu, 15 Jul 2010 07:50:33 +0200

Brussels – European Biotech lobby group EuropaBio has welcomed the inauguration of the EU’s new High-Level Group on Key Enabling Technologies (KET) that will be advising the...

Switzerland approves Intercell's Japanese encephalitis vaccine

Wed, 14 Jul 2010 07:11:00 +0200

Vienna – Swissmedic has approved IXIARO�, a vaccine against Japanese encephalitis from Intercell AG that is distributed and marketed by

National GMO bans � industry against dilution of GMO labeling threshold

Tue, 13 Jul 2010 07:35:04 +0200

Brussels/Frankfurt – Agrobiotech companies have warned against the implementation of national GMO bans on the basis of new guidelines that favour thresholds below the EU labelling...

Interview�We need a European lobby for GMOs�

Mon, 12 Jul 2010 09:24:15 +0200

Silvano dalla Libera is a maize farmer who runs a farm in Vivaro in the Friuli region of northern Italy. In 2004, dalla Libera co-founded Futuragra, a...

Germany launches EUR200 million biotechnology research programme

Mon, 12 Jul 2010 07:00:48 +0200

Berlin – Germany is to invest EUR200 million over the coming 15 years to develop the next generation of biotechnology processes. “The full potential of biotechnology isn’t yet...

Fresh cash for cancer therapies

Sun, 11 Jul 2010 14:58:25 +0200

Lysaker – Norwegian biopharmaceutical company PCI Biotech Holding ASA has strengthened the company’s equity by a11m (NOK90m) through a share issue of 2.25 million shares with...

GSK strikes deal with Genmab

Sun, 11 Jul 2010 14:57:13 +0200

London/Copenhagen – British drugmaker GlaxoSmithKline has changed the conditions of its EUR1.2bn licensing agreement with Danish antibody specialist Genmab. GSK announced it will...

Biobank and consortium find home

Sun, 11 Jul 2010 14:55:44 +0200

Stockholm – The Swedish Research Council is commissioning the Stockholm-based Karolinska Institute to host two new national infrastructures for research in biomedicine: the...

Improved drug response

Sun, 11 Jul 2010 14:50:39 +0200

T�bingen – A single infusion with the immune modulator cyclophosphamide before vaccination with Immatics’ multi-peptide tumour vaccine IMA901 improves response rate in patients...

The EMA is also built on fees

Sun, 11 Jul 2010 14:48:42 +0200

London – It’s bad news for the European Medicines Agency. A new Eurobarometer poll (see page 10) shows that many European citizens don’t trust scientists whose work has been...

Sensor project given EU funding

Sun, 11 Jul 2010 14:46:02 +0200

Brussels – The European Commission has awarded EUR2.8m to a project intended to create ultra-sensitive chemical sensors and smarter, cheaper infrared (IR) photodetectors....

IMI diabetes project

Sun, 11 Jul 2010 14:27:45 +0200

Brussels – The Innovative Medicines Initiative launched a EUR26m diabetes research project in mid-June. IMIDIA will focus on the factors that contribute to the functioning and...

Commission drafts measures to support sustainable biofuels

Sun, 11 Jul 2010 14:25:50 +0200

Brussels/Geneva – Biofuel production from cheap resources such as wood waste, corn stover or grass could be the next huge market for biotech. According to estimates from the...

Firms warn against altering GMO threshold

Sun, 11 Jul 2010 14:22:17 +0200

New coexistence rules designed by the European Commission to give EU member states the right to ban acreage of genetically modified organisms (GMOs) from their territories will...